Neopterin, a well-established biomarker for immune system activation, is found at increased levels in the cerebrospinal fluid of individuals affected by neurological/neurodegenerative diseases. Here, neopterin synthesis was investigated in different nerve cells (rodent and human) and in the mouse hippocampus under inflammatory stimuli. We also aimed to investigate whether neopterin preconditioning could modulate the inflammasome activation, a component of the innate immune system. Increased neopterin was detected in human nerve cells supernatants (highest secretion in astrocytes) exposed to lipopolysaccharide (LPS) and interferon-gamma (INF-γ) and in the hippocampus of mice receiving LPS (0.33 mg/kg; intraperitoneal). In parallel to the hippocampalincreased neopterin, it was observed a significant increase in the expression of the rate-limiting enzyme of its biosynthetic pathway, and both phenomena occurred before the inflammasome activation. Moreover, a significant inhibition of the inflammasome activation was observed in neopterin pre-conditioned human astrocytes, when challenged with LPS, by reducing IL-1β, caspase-1 and ASC expression or content, components of the NLRP3 inflammasome. Mechanistically, neopterin might induce eletrophilic stress and consequently the nuclear translocation of the transcription factor Nrf-2, and the anti-inflammatory cytokines IL-10 and IL-1ra release, which would induce the inhibition of the inflammasome activation. Altogether, this strongly suggests an essential role of neopterin during inflammatory processes.
A B S T R A C T
Neopterin, a well-established biomarker for immune system activation, is found at increased levels in the cerebrospinal fluid of individuals affected by neurological/neurodegenerative diseases. Here, neopterin synthesis was investigated in different nerve cells (rodent and human) and in the mouse hippocampus under inflammatory stimuli. We also aimed to investigate whether neopterin preconditioning could modulate the inflammasome activation, a component of the innate immune system. Increased neopterin was detected in human nerve cells supernatants (highest secretion in astrocytes) exposed to lipopolysaccharide (LPS) and interferon-gamma (INF-γ) and in the hippocampus of mice receiving LPS (0.33 mg/kg; intraperitoneal). In parallel to the hippocampalincreased neopterin, it was observed a significant increase in the expression of the rate-limiting enzyme of its biosynthetic pathway, and both phenomena occurred before the inflammasome activation. Moreover, a significant inhibition of the inflammasome activation was observed in neopterin pre-conditioned human astrocytes, when challenged with LPS, by reducing IL-1β, caspase-1 and ASC expression or content, components of the NLRP3 inflammasome. Mechanistically, neopterin might induce eletrophilic stress and consequently the nuclear translocation of the transcription factor Nrf-2, and the anti-inflammatory cytokines IL-10 and IL-1ra release, which would induce the inhibition of the inflammasome activation. Altogether, this strongly suggests an essential role of neopterin during inflammatory processes.
Introduction
Neopterin (d-erythro-neopterin; molecular weight, 253.21 g/mol), a by-product of the tetrahydrobiopterin (BH4) de novo biosynthetic pathway, is a well-established biomarker for immune system activation [1] . Neopterin production in humans has been linked to monocytic cells under interferon-γ (IFN-γ) or interleukin-1beta (IL-1β) stimulation, among others [2] . These stimuli trigger the up-regulation of the first rate-limiting step enzyme of the de novo pathway, guanosine triphosphate cyclohydrolase I (GTPCH). Upon this transcriptional up-regulation of the Gch1 gene (coding for GTPCH), its substrate, GTP, is converted into 7,8-dihydroneopterin triphosphate [3] . Then, 6-pyruvoyl tetrahydropterin synthase (PTPS) removes the phosphates to generate 6-pyruvoyl-tetrahydropterin, which is further converted to BH4 by sepiapterin reductase (SR) [3] . Under inflammatory conditions, GTPCH activity is increased up to 100-fold, while PTPS and SR are slightly increased. Consequently, PTPS becomes the rate-limiting enzyme in the pathway favoring neopterin formation [3, 4] . Thus, elevated levels of neopterin can be detected in the biological fluids and have been used as a biomarker of immune system activation in several acute and chronic pathologies, including viral infections, certain malignancies, allograft rejection, autoimmune and chronic metabolic diseases, as well as neurodegenerative and psychiatric disorders [5] [6] [7] [8] [9] .
Cerebrospinal fluid (CSF) or central neopterin has for decades been believed to reflect serum or plasma neopterin concentrations, and therefore is believed to have exclusively peripheral origin/production [5] . The suggestion that CSF neopterin had a central origin was proposed for the first time in 2013 by Kuehne et al., based on the estimated low quotient (1/40) for neopterin to cross the blood-brain barrier (BBB) [10] , and on the higher levels of neopterin in the CSF than in the plasma or serum of patients affected by neurological diseases with intact BBB function [11] . Soon after, our group demonstrated that neopterin is secreted into the supernatant of primary rat striatal astrocytes and of mouse hippocampal slices under cellular stress induced by the mitochondrial toxin sodium azide, supporting the view that this pteridine could be produced by nerve cells under oxidative stress conditions [12] . This information allowed the understanding of a wider range of neopterin concentrations in the CSF, compared to concentrations in the serum or plasma of healthy individuals.
Healthy adult subjects present plasma or serum neopterin levels up to 5-8 nmol/L [9, 11, 13, 14] while CSF neopterin levels vary from 5 to 50 nmol/L [10, 15] . Two to three times those serum/plasma neopterin levels are expected in pathological conditions characterized by immune system activation. For instance, neopterin reaches more than 15 nmol/L in plasma from non-treated HIV patients [16] and Alzheimer's disease patients in advanced stages of dementia [17] , and it reaches more than 40 nmol/L in patients with acute bacterial infections [18] . However, little is known about the pteridine extracellular functions in the CNS. Some studies have associated high levels of neopterin (higher levels than those found in pathological conditions) with oxidative stress, inflammation and apoptosis [19] [20] [21] [22] , while recent reports demonstrated that neopterin (at slight higher levels than in normal conditions) improves the antioxidant status in the mouse cerebral cortex [23] , prevents azide-induced reactive oxygen species (ROS) production and increases hemeoxygenase-1 (HO-1) content in rat primary astrocytes [12] . Furthermore, recent data from our group have shown that neopterin enhances cognition by activating antioxidant and anti-inflammatory pathways [24] .
IL-1β is one of the main stimuli involved in neopterin synthesis and release [2] . IL-1β is synthesized as a pro-form, and it is proteolytically cleaved into its mature form by active caspase-1 [25, 26] . The activation of pro-caspase-1 requires the olygomerization of a cytosolic multiprotein complex named inflammasome, which is composed of i) a sensor/receptor protein located in the cytosol that serves as a platform for the formation of the complex, ii) an adapter protein, ASC [apoptosisassociated speck-like protein containing a CARD (caspase recruitment domain)], and iii) an effector protein, active caspase-1 [27] . The NODlike receptor family, pyrin domain containing 3 (NLRP3), is the most studied inflammasome and it requires two steps to be activated; priming and activation. During priming, NF-κB activators induce the expression of pro-IL-1β and NLRP3. Then a second signal activates NLRP3, inducing caspase-1 activation and consequently maturation of IL-1β.
Although inflammasome activation is crucial for host defense, it has been demonstrated that sustained activation of inflammasomes underlies the pathogenesis of several diseases, including type 2 diabetes, Parkinson's disease (PD) and Alzheimer's disease, among others (for review see [28] ). Therefore, by inhibiting its activation, new avenues for the treatment of chronic diseases with inflammasome-associated processes have been proposed. However, a better understanding of the mechanisms involved in the activation of the inflammasome is necessary to allow for its modulation by small molecules, as recently proposed by [29] . In this scenario, for example, the ketone β-hydroxybutyrate [30] , prostaglandin E2 [31] and dopamine [32] have been demonstrated to be inhibitors of inflammasome activation in vitro and/ or in vivo. Thus, we investigated neopterin synthesis in the CNS under inflammatory conditions and its effect on the inflammasome NLRP3 activation in neopterin-preconditioned and LPS-stressed human and rat astrocytes.
Results and discussion

Neopterin is secreted by nerve cells after a pro-inflammatory challenge
Increased levels of neopterin in biological fluids is widely considered to be a sensitive biomarker for cell-mediated immune activation in several conditions, including viral infections, certain malignancies, allograft rejection, and autoimmune, metabolic, neurological and neurodegenerative diseases [5, 6, 8, 9] . However, the source of increased neopterin in the CNS, i.e. in the CSF of patients affected by some of these conditions, is not well understood. In this scenario, initially proposed that neopterin may be produced in the CNS, based on the estimated low quotient (1/40) for neopterin to cross the BBB [10] , and on the higher levels of neopterin in the CSF than in plasma or serum of patients affected by neurological diseases with intact BBB function [11] . Later, our group demonstrated that neopterin is secreted into the supernatant of primary rat striatal astrocytes [12] and of hippocampal slices [23] under cellular stress induced by the mitochondrial toxin sodium azide, supporting the view that this pteridine could be produced by nerve cells [12, 23] . In line with these previous results, the first set of experiments was designed to confirm that neopterin is accumulated in the brain of mice submitted to an inflammatory challenge. Fig. 1 shows neopterin serum secretion and hippocampal synthesis under an acute LPS (0.33 mg/kg; single dose; i.p.) inflammatory stimulus. Fig. 1A and Suppl. Fig. 1 show that serum neopterin levels increased significantly after 5 min, reaching a maximum peak at 15 min after the LPS injection, and remained at increased levels for up to 60 min [F (4,9) = 39.87; P < 0.001]. A similar pattern was observed in the hippocampus (Fig. 1B) [t (2) = 7.80; P < 0.01], where the Gch1 gene expression (a marker of neopterin formation) was significantly increased up to 8-fold [F (2,7) = 6.08; P < 0.05] (Fig. 1C) . Both events were strongly time-dependent (neopterin production: [β = 0.88; P < 0.05]; Gch1 gene expression: β = 0.79; P < 0.010]). In addition, Suppl. Fig. 1B shows that neopterin is also accumulated in the brain under a non-classical inflammatory stimulus. Mice exposed to MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; toxin employed to generate one of the most widely used experimental animal models to mimic PD) elicited the accumulation of neopterin up to 8-fold in the mouse striatum. Previous studies have already shown increased Gch1 gene expression and content in the mice locus coeruleus, but only after 4 and 6 h of LPS systemic administration (about 0.2 mg/kg), respectively [33, 34] . Thus, this is the first work to demonstrate that LPS Fig. 1 . Lipopolysaccharide (LPS)-induced rapid peripheral and central neopterin production. Sixty-day old mice received a single LPS intraperitoneal injection (0.33 mg/kg), and after 5 to up to 60 min the serum and the hippocampi were collected for biochemical analyses. Neopterin levels (A, B) was measured by HPLC and Gch1 gene expression (C) was analyzed by RT-PCR. Gene expression is shown as the ratio of the studied transcripts relative to β-actin measured in triplicate. Values are presented as mean ± SEM (n = 5 animals per group). *P < 0.05; **P < 0.01, ***P < 0.001, vs. controls (One-way ANOVA followed by the post hoc of Dunnett).
induces rapid systemic and central neopterin production and secretion. Additionally, these findings do not support a simple diffusion mechanism through the BBB, strengthening the hypothesis that neopterin is produced in the CNS, and the levels in the CSF do not exclusively reflect plasma/serum levels. The next step in the experiment, before testing the effect of neopterin on inflammasome activation, was designed to assay for endogenous neopterin production within primary human CNS cells, also under a classical inflammatory stimulus. Fig. 2 shows neopterin production by human neurons, astrocytes and microglia under two classical pro-inflammatory stimuli, LPS and IFN-γ (Fig. 2) . Fig. 2A shows increased levels of neopterin in the supernatant of human neurons exposed to LPS (10 and 100 ng/mL) and IFN-γ (5 and 40 ng/mL) for 24 h [H (4) = 38.13; P < 0.001] or 48 h [H (4) = 36.44; P < 0.001], finding significantly higher levels of the pteridin after 48 h [X 2 (9) = 52.87; P < 0.001]. The figure shows that neurons were more sensitive to the direct effect of IFN-γ than to LPS, with twice more neopterin secretion at 24 h and 48 h. In agreement, the ratio between 48 h / 24 h Fig. 2 . Pro-inflammatory stimulus-induced neopterin production in human primary nerve cells. Human primary neurons (A), astrocytes (C) and microglia (E) were exposed to LPS (10 and/or 100 ng/mL) and IFN-γ (5 and/or 40 ng/mL) for 24 (Fig. 2B) . However, the cell exposure to concentrations of 10 or 100 mg/mL LPS elicited similar neopterin values in the supernatants. Fig. 2C shows a similar secretion profile for astrocytes; however, higher levels of the pteridin were released into the supernatant after 24 h [H (4) (Fig. 2D ). Fig. 2E shows that microglia also release neopterin. Due to the low recovery of microglia cells from the human fetal tissue, only the highest concentrations of the inflammatory stimuli were tested. The figure also showed a similar secretion profile for both 24 h [H (2) = 12.31; P < 0.001] and 48 h [H (2) = 12.31; P < 0.001]), with significantly higher neopterin levels after 48 h [Χ
2
(1) = 6.00; P < 0.05], but with lower concentration in the medium. In addition, IFN-γ had no differential effect on the ratio between 48 h / 24 h for neopterin production (Fig. 2F ). This constant ratio in the microglia seems to be a characteristic behavior of immune cells, which depends on increased GTPCH activity for neopterin production. In line with this, Werner and coworkers demonstrated IFN-γ stimulation (12.5 ng/mL) elicited a linear GTPCH activity increase, reaching a plateau after 30 h of exposure in T cells [3] .
IFN-γ is traditionally one of the main stimuli for neopterin formation [5, 35, 36] due to its ability to positively modulate Gch1 expression [3] . LPS challenge induces the IFN-γ release from activated Th1 cells during the initiation of the immunological cellular response after the interaction with its saturable receptor TLR4 (Toll-like receptor 4) [37] , which mainly leads to the synthesis of pro-inflammatory cytokines and chemokines [38] . Under these conditions it is known that immune cells, including activated monocytes, macrophages or dendritic cells up-regulate the key enzyme in the inflammatory process, nitric oxide synthase type II (NOSII) in order to elicit the production of nitric oxide (NO), a toxic defense molecule. The consequent increased NOS activity for sustaining NO production requires higher concentrations of its cofactors, including the mandatory cofactor BH4. To couple these processes, Gch1 is up regulated through positive feedback, leading to the accumulation of 7,8 dihydroneopterin (because of the low expression of PTPS), with the posterior conversion to neopterin [39, 40] . Thus, considering the formation of neopterin linked to the de novo BH4 pathway it was previously proposed that biogenic amines-producing cells (neurons) might be also responsible for the central production of neopterin. This is further supported by the fact that BH4-dependent neurotransmitter brain regions, including the hippocampus, amygdala, locus coeruleus, substantia nigra, raphe nucleus, nucleus accumbens, caudate and putamen from humans without any clinical history of neurological diseases, have measurable levels of neopterin [41] . Moreover, since microglia and astrocytes respond to IFN-γ and express NOS in a similar manner of peripheral macrophages [42] , these cells were also proposed as potential central sources of neopterin [12] . The data presented here showed for the first time that human nerve cells synthesize and release neopterin upon classical pro-inflammatory stimulus. Furthermore, the data also demonstrate that astrocytes are the most representative neopterin producers (up to 39 nmol/L when treated with IFN-γ 40 ng/ mL for 48 h) in our experimental design. The data is in agreement with previous results from our group showing that rat primary astrocytes released neopterin, up to 30 nmol/L, under mitotoxic conditions induced by azide exposure [12] . The findings indicate that neopterin is synthesized and released by cells of the CNS of rodents and humans. However, the exact role of the compound needs to be uncovered.
Neopterin is an early biomarker of inflammasome activation
The second main objective of this study was to investigate whether neopterin prevents inflammasome activation, by performing pre-conditioning studies in human primary brain cells. Therefore, we first tested in an in vivo system whether the release of neopterin precedes the activation of the inflammasome after an inflammatory challenge. In addition, the intraperitoneal LPS-induced inflammasome priming and activation was verified through both pro-IL-1β gene expression (priming) and active caspase-1 content (activation) analyses. Fig. 3 shows markers of inflammasome activation after a single LPS (0.33 mg/ kg; i.p.) challenge in adult mice. Fig. 3A shows the classical peak of IL-1β in the serum at 4 h (240 min) after the inflammatory stimulus [F (5, 12) = 315.60; P < 0.001]. Also observed is a significant increase of the cytokine after 1 h of the challenge [t (5) = 3.57; P < 0.01], which was accompanied by increased IL-1β expression [F (3,4) = 6.88; P < 0.05] (Fig. 3B ) and active caspase-1 (p20) content [F (4,7) = 12.39; P < 0.01] (Fig. 3C ) in the hippocampus of the LPS-injected animals. Since caspase-1 activation is mediated by the inflammasome [25, 43] , our data pointed to the activation of the protein complex in the mouse hippocampus. According to this information, it can be suggested that neopterin release precedes ( Fig. 1A-C) the activation of the inflammasome after the inflammatory challenge, pointing to neopterin as an early biomarker of inflammasome activation in the CNS.
The LPS-induced inflammasome activation in the brain has already been demonstrated in mice by the increased content of the proteins IL-1β, active caspase-1 (p20) and NLRP1 in the cerebral cortex [44] , and by increased serum IL-1β levels [45, 46] . These studies used higher doses of LPS in their experiments (5 -25 mg/kg; i.p.), around 15-75 times higher than those used in our study; however, they also elicited a significant increase of serum IL-1β after 3 h of the LPS administration (25 mg/kg) [46] . In addition, the inflammasome activation in the brain has only been investigated after 6 h of mice being challenged to LPS 5 mg/kg [44] , thus this is the first report to show that a peripheral inflammatory stimulus rapidly triggers the complex activation in the Fig. 3 . Lipopolysaccharide (LPS)-induced rapid inflammasome-dependent IL-1β activation. Sixty-day old mice received a single LPS intraperitoneal injection (0.33 mg/kg) and after 5-60 min the serum and the hippocampi were collected for biochemical analyses. Serum IL-1β levels (A) and hippocampal IL-1β gene expression (B) were measured by ELISA and RT-PCR, respectively. Gene expression is shown as the ratio of the studied transcripts relative to β-actin, measured in triplicate. Caspase-1 (C) content was assessed by Western blot techniques and quantified by densitometry. β-actin was used to control the quantity of the protein sample. Values are presented as the mean ± SEM (n = 3-5 animals per group). One representative Western blot is shown for caspase-1 content (C). *P < 0.05; **P < 0.01, ***P < 0.001, vs. controls (One-way ANOVA followed by the post hoc of Dunnett; Student t-test for unpaired samples).
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brain.
The increased levels of IL-1β, the final product of inflammasome activation, and neopterin after in vivo and in vitro LPS exposure have already been described by our group and others [24, 47, 48] . However, here it was shown for the first time that the serum increased pteridine secretion (Fig. 1A) precedes the increased IL-1β levels, and that hippocampal accumulation of neopterin occurs also prior to the increased IL-1β expression in the hippocampus (Fig. 1B) . These data point out serum neopterin as an early biomarker of inflammasome activation in the CNS, and probably indicates a protective response to the upcoming unfavorable events elicited by the inflammatory environment.
Neopterin attenuates LPS-induced inflammasome activation in human primary astrocytes
After confirming that brain cells release neopterin, that astrocytes are the main producers under a classical inflammatory status, and that the release of the pteridine precedes the maturation and secretion of IL-1β, we further investigated the effect of neopterin preconditioning on the activation of the inflammasome.
With more than 3000 reports at PubMed showing increased peripheral neopterin levels as a biomarker for different inflammatory conditions, the biological effects of the pteridine are still not clearly defined. The extracellular effect of this pteridine has been recently reviewed by our group [12] . Most of the available information in the literature is contradictory mainly due to the concentrations used; some studies have associated high levels of neopterin (higher levels than those found in pathological conditions) with oxidative stress, inflammation and apoptosis [19] [20] [21] [22] . The neopterin levels used in these studies surpassed up to two thousand times the neopterin blood / CSF levels of a healthy population [9] [10] [11] 13, 14] , making it difficult to translate to human physiology. However, it was shown by our group that neopterin at levels slightly higher than in normal conditions improves the antioxidant status in the mouse cerebral cortex [23] , prevents azide-induced ROS production and increases HO-1 content in rat primary astrocytes [12] . In addition, the intracerebral injection of neopterin activates antioxidant and anti-inflammatory pathways and reduces the threshold for generating the long-term potentiation, enhancing therefore the cognitive processes [24] . Thus, neopterin was proposed by our group as a cytoprotective molecule synthesized and secreted by the nerve cells as a compensatory response to damage or inflammation. Thus, the next step was to investigate whether the preconditioning with neopterin for 24 h, before the inflammatory scenario was established, modulates the inflammasome activation in non-immune LPS-treated cells.
Initially, the appropriate LPS concentrations for treating human primary astrocytes were determined in rat astrocytes (C6 rat cell line) by following the minimum LPS concentration that generated the secretion of caspase-1 (mature/active form; p20; Suppl. Fig. 2A ) into the supernatant. Afterwards, human primary astrocytes were exposed to 5 μg/mL LPS concentration up to 24 h, in order to determine the best exposure time to the inflammatory stimulus that elicited the highest levels of IL-1β and caspase-1 gene expression (Suppl. Fig. 2B and C) . Therefore, human primary astrocytes pre-conditioning was performed with crescent concentrations of neopterin (5-500 nM) during 24 h and then cells were exposed to 5 μg/mL LPS (Scheme 1). It should be stressed that the median concentration of the neopterin curve (50 nmol/L) represents the quantity of neopterin released by astrocytes when exposed to an inflammatory stimulus, and also the expected values of CSF neopterin in a healthy population [10, 12] . Fig. 4A shows that neopterin-preconditioning significantly inhibited LPS-induced IL-1β gene expression [F (3, 12) = 11.92; P < 0.001] and secretion [F (3, 4) = 23.49; P < 0.01] (Fig. 4B) . It can also be observed in the figure that the inflammasome-independent cytokines IL-6 and TNF-α were not affected by the neopterin pre-conditioning ( Fig. 4C and D) . These results suggest that neopterin may not exert its anti-inflammatory properties described previously by our group [24] by inhibiting the inflammasome priming (pro-IL-1β expression) or by inhibiting the activation of NF-κB, but by inhibiting inflammasome assembly.
The NLRP3 inflammasome, the most studied inflammasome, is constituted by the NLRP3 receptor, the adapter protein ASC and the effector caspase-1, which finally processes pro-IL-1β to IL-1β Fig. 4E shows that neopterin-preconditioning significantly inhibited caspase-1 gene expression in human primary astrocytes [F (3, 6) 
Neopterin preconditioning triggers Nrf2 activation in C6 astroglial cells
Mechanistically, the inhibitory effect of neopterin on inflammasome activation could be related to the previous antioxidant properties reported for the molecule. showed that after a single administration of intracerebroventricular neopterin (0.4 and 4 pmol), glutathione and glutathione dependent antioxidant enzymes were significantly increased in the mouse hippocampus [23] . Moreover, showed that neopterin per se induces increased HO-1 content in rat striatal primary astrocytes [12] , which is known to exhibit protective biological activities, including potent antioxidant and anti-inflammatory effects [49] . HO-1 is an early marker of Nrf2 activation [50] , a transcription factor that once activated confers cytoprotection. In agreement with our previous results, here we showed the activation of the Nrf-2 pathway by measuring the content of Nrf-2 by flow cytometry (Fig. 5A and B) , the nuclear translocation of Nrf-2 by western blott (Fig. 5C and D) , the content of the downstream protein controlled by Nrf-2/ARE pathway, HO-1 ( Fig. 5G and H) , and increased mitochondrial function (Fig. 5I-L) , which has been linked to Nrf-2 activation [50] . Fig. 5A and B shows that the exposure of rat astrocytes to neopterin (3 h; 50 nM) significantly increased the content of Nrf2 [t (3) = 5.81; P < 0.01]. Furthermore, 50 nM neopterin elicited a significant nuclear translocation of the Nrf2 starting 1 h after the exposure, and remaining activated for at least 4 h [F (4,10) = 18.21; P < 0.001] (Fig. 5C and D) . As shown, a rapid activation of Nrf-2 was observed after 0.5 h exposure. However, the expected downstream effects were observed after exposing the cells to neopterin for 24 h. Fig. 5G-H,I -L show the increased content of HO-1 [t (4) = 4.38; P < 0.05] and the increased mitochondrial activity (increased activity of complexes I [t (4) = 5.45; P < 0.001] and IV [t (4) = 4.38; P < 0.001], increased basal oxygen consumption [t (4) = 11.02; P < 0.001] and reduced lactate formation [F (3,25) = 14.13; P < 0.001]), respectively. In this scenario, the increased activities of the mitochondrial enzyme complexes I and IV are in agreement with increased oxidative metabolism, denoted by increased oxygen consumption and reduced lactate production. Moreover, 24 h exposure to neopterin also attenuated LPS-induced H 2 O 2 production (F (1,8) = 14.45; P < 0.01; Fig. 5M ). We have also shown similar neopterin antioxidant effects in rat primary striatal astrocytes exposed to azide, with reduced oxidation of dichloro-dihydro-fluorescein diacetate (DCFH) and reduced lactate formation [12] . The reduction production of lactate might result from increased phosphate pentose pathway to sustain increased glutathione peroxidase/glutathione reductase activity. Indeed, we also reported increased activity of glutathione peroxidase/glutathione reductase, and well as, increased levels of glutathione in brain from naïve mice treated intracerebroventricularly with neopterin [23] . Two systems required for hydrogen peroxide detoxification. Thus, it is feasible that neopterin increases the mitochondrial oxidative metabolism; however, the pteridine also stimulates the antioxidant response in the cell, resulting in a lower levels of hydrogen peroxide. Furthermore, a single intracerebral injection of 0.4 and 4 pmol neopterin did not induce changes in the mitochondrial enzyme activities (complexes I, II and IV) 3 h after the administration, suggesting that neopterin will induce the cytoprotective effects after inducing specific gene expression and protein synthesis. It should be noted here that the neopterin doses of 0.4 and 4 pmol were calculated to generate a slight increase in CSF neopterin levels, as previously reported by our group [23] .
In order to better understand the mechanism by which neopterin stimulates the Nrf-2 activation, we exposed naïve C6 cells to 50 nM neopterin (15 min; 37°C) and the oxygen consumption was measured ( Fig. 5E and Suppl. Fig. 3A-C) . The addition of the pteridine did not change the mitochondrial basal respiration, indicating that neopterin per se does not auto-oxidase or donate electrons to the respiratory chain creating a futile cycle. This was further confirmed by the co-incubation of 50 nM neopterin with solutions of artificial and natural electron acceptors and by following the absorbance (10 mM potassium ferricyanide; 0.5 mM DCIP; 30 μM reduced cytochrome c at 37°C for 15 min). It can be observed in the figure that neopterin did not reduce potassium ferricyanide or DCIP solutions (Suppl. Fig. 3D-E) . In addition, cytochrome c was not oxidized by neopterin exposure (Suppl.
on lipopolysaccharide (LPS)-induced inflammasome activation in human primary astrocytes. Fig. 4 . Neopterin pre-conditioning negatively modulated the activation of inflammasome in human primary astrocytes exposed to lipopolysaccharide (LPS). Human primary astrocytes were pre-treated with neopterin (0-500 nM) for 24 h and then activated with LPS (5 μg/mL). After 24 h of LPS stimulation, RNA was extracted, purified and the transcription of IL-1β (A) and caspase-1 (E) were determined by quantitative RT-PCR. Gene expression is shown as the ratio of the studied transcripts relative to β-2-microglobulin (B2M) measured in triplicate. After 48 h of LPS stimulation, the supernatants were collected and IL-1β (B), IL-6 (C), TNF-α (D), IL-10 (I) and IL-1ra (J) secretion were determined by using ELISA commercial kits. The cell lysates were collected and prepared to determine caspase-1 (F) and ASC (G) content by Western blot techniques and quantified by densitometry. One representative Western blot is shown for caspase-1 and ASC content (H). GADPH expression was used to control the amount of protein sample. See Scheme 1 for the whole experimental design in human nerve cells. Values are presented as mean ± SEM of three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001, vs. LPS (One-Way ANOVA followed by the post hoc of Dunnett).
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Fig . 3F ). These simple experiments suggest neopterin per se does not induce free radical species generation due to auto-oxidation or to a redox-cycle. Therefore, it could be concluded that the increased respiratory chain activities observed after 24 h exposure, it is not due to neopterin auto-oxidation, at least at the concentrations used in this study which are very close to those found in vivo. Finally, considering that electrophilic stresses (i.e. free radical generation) can activate the Nrf2/ARE pathway, and induce the expression of a set of cytoprotective genes [50] , we next measure the generation of superoxide radical in the pre-conditioning neopterin/LPS cell system. Fig. 5N shows that neopterin preconditioning and the LPS treatment increased the production of superoxide radical, which was not prevented by the pteridine [F (1,33) = 8.812; P < 0.01]. Therefore, it could be speculated that in our conditions neopterin can induce a weak scenario of electrophilic stress by increasing superoxide radical levels, which culminates in higher cellular antioxidant resistance. The source of superoxide radical production might be the increased respiratory activity induced after 24 h of neopterin pre-conditioning. However, additional experiments are needed to elucidate this potential mechanism.
Most of the already described compounds with capacity to inhibit/ attenuate the inflammasome activation were characterized as antioxidants or inhibitors of NF-κB, caspase-1, NLRP3 or ASC activation (for review see [28] ). Some examples are the antioxidants ebselen and resveratrol [51, 52] , or the endogenous compounds, prostaglandin E2 and dopamine [32] . Thus, neopterin comes as an endogenous compound with the ability to inhibit the inflammasome activation that should be added to this list. In addition, the capacity of neopterin to increase Nrf2 content and to induce its nuclear translocation has already been described for various other compounds with anti-inflammasome activities, for example, the bioactive compounds of green tea, namely epigallocatechin-3-gallate, or citral found in the chinese herbal medicine Litsea cubeba [53, 54] . However, none of them are endogenous compounds.
Finally, neopterin-preconditioning increased the content of the antiinflammatory cytokines IL-10 and IL-1ra (IL-10: [F (3,4) = 7.63; P < 0.05]; IL-1ra: [F (3,4) = 11.09; P < 0.05]) (Fig. 4I-J) . Both, IL-10 and IL-1ra have been shown to inhibit inflammasome activation in vitro and in vivo, respectively. IL-10 (50 ng/mL) inhibited NLRP3 expression, caspase-1 activation and IL-1β secretion in macrophages from mice stimulated with LPS (0.2 mg/mL) plus ATP (5 mM) [55] , while anakinra (25 mg/kg; i.p.), an IL-1ra biological drug, reduced NLRP3-dependent caspase-1 activity and pro-inflammatory cytokines expression induced by chronic ethanol ingestion in the mice' cerebellum [56] . In line with this, it has been reported that both IL-10 and IL-1ra synthesis are up regulated by Nrf2 in vitro and in vivo [57, 58] . Thus, the Nrf2/HO-1 pathway may be the mechanism by which neopterin induces IL-10 and IL-1ra secretion and inhibits inflammasome activation. Taking into account that IL-10 synthesis can be up regulated by IL-6, due to IL-6's ability to initiate the expression of the transcription factor c-Maf, an IL-10 regulator [59, 60] , the lack of effect of neopterin pre-conditioning on IL-6 levels might also contribute to the anti-inflammatory status generated by the pteridin.
Conclusion
Here we report for the first time that human primary nerve cells synthesize neopterin and that pre-conditioning human primary astrocytes with neopterin inhibits inflammasome activation. The suggested involved mechanisms are linked to the activation of the Nrf2 pathway, which will further enhance the cellular antioxidant defenses and the anti-inflammatory environment. Further understanding of the mechanism involved in the activation of the NLRP3 inflammasome and the identification of endogenous inhibitors will contribute to the development of effective therapeutics for the treatment of inflammasome-associated diseases, and may also represent important steps towards modifying the progression of various neurological diseases. . The basal oxygen consumption was investigated following the addition of crescent concentrations of neopterin (0.5 -500 nM) (E). C6 cells were exposed to 50 nM neopterin for 24 h and the content of hemeoxygenase-1 (HO-1; G), the activities of the mitochondrial complexes I (I) and IV (J), the basal oxygen consumption (K), the release of lactate (L) were analyzed. HO-1 was assessed by Western blot and a representative image is shown (H). The mitochondrial activities were spectrofotometrically measured, the oxygen consumption was assessed in a Seahorse oximeter (Agilent, USA), the lactate levels were measure by using a lactimeter (YSI, USA). C6 cells were pre-treated with neopterin (50 nM) for 24 h and then activated with LPS (5 μg/mL). After 24 h of LPS stimulation, it was evaluated hydrogen peroxide (M) and superoxide anion (N) generation. For (N), the cells were incubated with the probe MitoSox™ (5 μM) for 10 min and the cell fluorescence recorded using a microscope integrated to a digital camera. For (M), after LPS exposure, the cells were incubated with Amplex® Red (300 nM) and the kinetics of hydrogen peroxide generation followed through spectrophotometry after the addition of horseradish peroxidase. Sixty-day old mice received a single neopterin intracerebral injection (0.4 and 4 pmol) and after 3 h the mitochondrial complexes I, II and IV were spectrofotometrically measured in the hippocampus (F). Values are presented as mean ± SEM of three to five independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001, vs. 0 or vehicle (Student's t-test or One-Way ANOVA followed by the post hoc of Dunnett); # P < 0.05 vs. LPS (Two-Way ANOVA followed by the post hoc of Tukey).
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4. Material and methods
Animals
Adult male Swiss albino mice were obtained from the Central Animal House of the Universidade Federal de Santa Catarina, Florianopolis-SC, Brazil. The animals were maintained in a 12-h light/ dark cycle in a constant temperature (22 ± 1°C) colony room, with free access to water and protein commercial chow (Nuvital-PR, Brazil). The experimental protocol was approved by the Ethics Committee for Animal Research (PP00760/CEUA) of the Universidade Federal de Santa Catarina, Florianopolis-SC, Brazil, and followed the International Guiding Principles for Biomedical Research Involving Animals, as issued by the Council for the International Organizations of Medical Sciences (available at http://www.cioms.ch/frame_1985_texts_of_ guidelines.htm).
Maintenance and treatment of C6 astroglial cell line
The rat astroglioma C6 cell line was obtained from the American Type Culture Collection (Rockville, Maryland, USA). The cells were seeded in flasks and cultured in Dulbecco's modified eagle's medium (pH 7.4) containing 5 % fetal bovine serum, sterile antimycotic solution 100 x: penicillin 100 IU / mL, streptomycin 0.1 mg/mL, and amphotericin 0.25 μg/mL, in a 95 % O 2 and 5 % CO 2 humidified atmosphere, at 37°C. Exponentially growing cells were detached from the culture flasks using 0.05 % trypsin/ethylene-diaminetetracetic acid and seeded in 6 well plates (5 × 10 4 cells/well). After cells reached confluence, the culture medium was removed by suction and the cells were exposed to LPS 1 and 5 μg/mL for 24 h and the cell lysate and supernatant were collected and prepared for Western blot analyses. In some experiments cells were exposed to 50 nM neopterin for 0.5-4 h and collected for Western blot, stained for flow cytometry or used for oxygen consumption analyses. In order to quantify lactate release, the cells were exposed to Neopterin 5 -500 nM for 3 h when the cell supernatant was collected. For superoxide anion and hydrogen peroxide detection, C6 cells were pre-exposed to 50 nM neopterin for 24 h and co-exposed with LPS 5 μg/mL for further 24 h.
Maintenance and treatment of primary cell culture
Human primary cells were obtained from 16 to 19-week-old fetuses collected following therapeutic termination with informed consent. All experiments followed the ethical standards in accordance with the World Medical Association (Declaration of Helsinki) for experiments involving human subjects and the Australian National Statement on Ethical Conduct in Human Research (2007) (HREC Application REF 5201300330) . Primary neurons, astrocytes and microglia culture were prepared from the mixed brain cell cultures, and maintained using a protocol previously described by our group [61] . Cerebral portions were washed with PBS and dissociated by repeated pipetting.
The neuronal cell culture was prepared by centrifuging the suspension at 500 x g for 5 min and the cell pellet cultured by plating the mixed cell suspension in culture dishes coated with Matrigel (1:20 in Neurobasal) and maintained in Neurobasal medium supplemented with 1 % B-27 supplement, 2 mM Glutamax, 1 x antibiotic-antimycotic, 5 mM HEPES and 2 mM glucose for 7-10 days at 37°C in a humidified atmosphere containing 5 % CO 2 . The medium was subsequently changed 2 days after plating and then every 3 days thereafter.
Neuronal cells were characterized by positive immunostaining for microtubule-associated protein-2 and NMDA receptor-1 [62] , ATPbinding cassette transporters ABCA1, ABCA2, and ABCG1 [63] , and the kynurenine pathway enzymes indoleamine-2,3-dioxygenase tryptophan 2,3-dioxygenase, α-amino-β-carboxymuconate-semialdehyde decarboxylase, quinolinate phosphoribosyltransferase, kynurenine amino transferase-I and kynureninase [64] .
For the astrocyte cell culture, the cell pellet was suspended in RPMI 1640 medium containing 10 % heat-inactivated FCS, 1 % glutamax-1, 1 % antibiotic-antimicrobial liquid, 0.5 % glucose. Then, cells were plated onto 75 cm 2 culture flasks and incubated at 37°C. The medium was changed on the 3rd, 5th and 10th day. Microglia were detached from the cultures by mechanically shaking the flasks for 2 h at 220 rpm at room temperature. The astrocytes were trypsinized and plated again at least three times to further purify and isolate astrocytes from contaminating microglia and neurons. Astrocytes were left to recover for 3 days after each passage. Cell cultures at 3-4 weeks were used in all the experiments. Exponentially growing cells were detached from the culture flasks using 0.05 % trypsin/ethylene-diaminetetracetic acid and seeded in 6 well plates (1 × 10 5 cells/well).
For the microglia cell culture, the original mixed brain cell culture was shaken at 220 rpm for 2 h, floating cells were centrifuged, transferred to 6 well plates at a density of 1×10 5 cells / mL and grown in DMEM supplemented with 10 % fetal calf serum (FCS), 1 % Glutamax, 0.5 % glucose, IL-3 (300 IU / mL), macrophage colony-stimulating factor (M-CSF) (50 IU/mL), and 1 % penicillin/streptomycin. Cell culture purity was confirmed by immunocytochemical staining for astrocyte protein, glial fibrillary acidic protein (GFAP), in the neuronal and microglial cultures and for the neuronal protein anti-βIII-tubulin, in astrocytes culture.
LPS-injected mice
Fifty adult male mice were randomly divided into five experimental groups and intraperitoneally (i.p.) injected with saline or Escherichia coli LPS (0.33 mg/kg; serotype 0111:B4, Sigma, St. Louis, MO). Mice were euthanized by decapitation after 0, 5, 15, 30, 60 or 240 min. LPS was diluted in saline. Control animals received vehicle injections (saline; i.p.). The LPS dosage was selected because of the already known pro-inflammatory cytokine response in the adult mice' brains [24, 65, 66] . Serum and hippocampi were collected and stored at −80°C for further analyses.
Intracerebroventricular administration of neopterin
Free-hand transcranial injections were made for local injections in ventricle (i.c.v.) of male adult Swiss mice; the relative coordinates were used according to the atlas of Paxinos and Franklin [67] . The coordinates relative to Bregma were anterior: −0.5 mm; lateral: ± 1.0 mm; vertical: −2.0 mm for the left ventricle. Animals were injected with neopterin or vehicle (artificial cerebrospinal fluid; aCSF) under diethyl ether anesthesia (1.9 % in a cotton ball inside a conical tube or small chamber) in Swiss mice by using a Hamilton syringe connected by Pe-10 polyethylene tubing. The delivered volume was 1 µL over oneminute period. The i.c.v. injected dose in mice (0.4 pmol) was chosen in order to elicit a transient increase of CSF neopterin of up to 50 nM. For the calculations, a 35 µL was considered as the maximum CSF volume [68] . After euthanasia, the hippocampi were collected and stored at −80°C for further analyses.
Exposure of human brain cells to LPS
The first experimental protocol was performed to evaluate neopterin production by brain nerve cells. Human primary neurons, astrocytes and microglia cultures were exposed to LPS 10 and 100 ng/mL or IFN-γ 5 and 40 ng/mL for 24 h and 48 h. Afterwards, the supernatants were collected for neopterin quantification.
Neopterin preconditioning of human astrocytes with subsequent exposure to LPS
Human primary astrocytes were exposed to neopterin and LPS according to Scheme 1. Briefly, after removing the regular culture medium by suction, cells were conditioned with neopterin (0-5000 nM) for 24 h. Afterwards, the cells were stimulated with 5 μg/mL LPS. After 24 h of LPS exposure, cells were collected and prepared for RT-PCR analyses. Supernatants and cell lysate were collected after 48 h of coexposure to neopterin plus LPS for cytokine measurements by ELISA and Western blot analyses, respectively.
Quantification of neopterin by HPLC and ELISA
Serum and supernatants were precipitated by adding one volume of trichloroacetic acid 5 %, and hippocampi were homogenized in 100 µL of the same solution. Samples were centrifuged at 14,000 × g for 10 min at 4°C. Twenty µL of supernatant were transferred to a HPLC (Alliance e2695, Waters, Milford, USA) vial for analysis. The supernatants were injected into the system with a mobile phase consisting of a 15 mM potassium phosphate buffer pH 6,4. The identification and quantification of neopterin was performed by a multi-wavelength fluorescence detector (module 2475, Waters, Milford, USA) with an excitation wavelength of 350 nm and an emission of 430 nm [12, 23] . Under these conditions the retention time of neopterin was approximately 4.7 min, with a total running time of 8 min. The results were expressed in nmol/L for serum and supernatants and pmol/mg protein for the hippocampus.
Blood neopterin levels assessed by HPLC were confirmed by ELISA by using a commercial kit (IBL international GmbH, Hamburg, Germany), and following the manufacturer's instructions. The levels of neopterin were estimated by interpolation from a standard curve by colorimetric measurements at 450 nm on an ELISA plate reader (Infinite® 200 PRO TECAN, Männedorf, Switzerland). Results were expressed in nmol/L.
Reverse transcription polymerase chain reaction (RT-PCR)
Total RNA was isolated from the mouse hippocampus by using a commercial kit (Tri-reagent protocol; Sigma; Saint Louis, USA), and according to the technical recommendations of the manufacturer. The concentration and purity of the extracted RNA was determined on a NanoDrop spectrophotometer at 260 nm and 280 nm. cDNA was synthesized from up to 1 µg of total RNA using M-MLV Reverse Transcriptase kit (Sigma; Saint Louis, USA). Five µL of cDNA product (equivalent to 5 ng RNA) was used per 15 µL reaction mix in each well, with 8.5 µL express SYBR green qPCR super mix universal (Invitrogen; Carlsbad, USA) and 1 µL of each primer (0.3 µM). Each sample was run in triplicate and two PCR controls were included for each running step using 5 µL aliquot of Reverse Transcription negative control and/or water instead of the sample. The oligonucleotide sequences of the primers for mice samples used for RT-PCR are listed in Table 1 . The realtime PCR was performed in the ABI PRISM 7900HT (Applied Biosystems; Foster City, USA), in the Multiuser Laboratory for Biological Studies (LAMEB, CCB, UFSC, Brazil).
Total RNA was isolated from brain cells after 24 h of LPS stimulation. Human primary astrocytes were washed three times with PBS (1x) and RNA was extracted using an RNeasy mini kit (Qiagen; Valencia, USA). cDNA was synthesized from up to 1 µg of total RNA using superscript® VILO™ MasterMix (Invitrogen; Carlsbad, USA). Five µL cDNA product (equivalent to 5 ng RNA) was used per 20 µL reaction mix in each well, with 10 µL express SYBR green qPCR super mix universal, and 0.6 µL of each primer (10 µM). Each sample was run in triplicate and two PCR controls were included as described above. The oligonucleotide sequences of the primers used for human samples RT-PCR are listed in Table 2 . The real time PCR was performed in the ViiA™ 7 (Life technologies / Applied Biosystems, Carlsbad, USA) instrument in the Research Laboratory of the Faculty of Medicine and Health Sciences, Macquarie University, Australia.
After 2 min of incubation at both 50°C and 95°C, DNA amplification occurred over 40 cycles (about 10 min) of 15 s incubation at 95°C, followed by 1 min incubation at 60°C. The melting curve was run at the end to confirm the identity and purity of the PCR. mRNA levels were expressed as fold change from the control using the delta CT method, after adjustment according to levels of the reference housekeeping gene, β-actin or β-2-microglobulin (B2M).
Serum IL-1β measurement
Serum IL-1β levels were determined by ELISA (R&D Systems, MN). In brief, mice were euthanized by decaptation and the blood immediately collected. The serum was used to measure IL-1β levels using the mouse cytokine ELISA kits from R&D Systems (Minneapolis, MN, USA), according to the manufacturer's instructions. The levels of cytokines were estimated by interpolation from a standard curve by colorimetric measurements at 450 nm (correction wavelength 540 nm) on an ELISA plate reader (Infinite 200 PRO TECAN Switzerland). Assays were sensitive to 1.5 pg/mL of IL-1β inter-and intra-assay coefficients of variation being less than 10 %. The results were expressed as picograms per milliliter (pg/mL).
Western blot analysis
The hippocampi were homogenized in 2.5 volumes of 50 mM Tris, pH 7.0, containing 1 mM EDTA, 100 mM NaF, 0.1 mM PMSF, 2 mM Na 3 VO 4 , 1 % Triton X-100, 10 % glicerol and protease inhibitor cocktail (Roche, Mannheim, Germany). Then, the samples were centrifuged at 10.000 × g for 10 min at 4°C, boiled at 100°C for 5 min. The protein content was quantified by the Lowry's method [69] . Samples were diluted in 25 % 100 mM Tris Buffer (pH 6.8, with 40 % glycerol and bromophenol blue) and 8 % β-mercaptoethanol. An aliquot of 50 μg of total protein was size-separated by electrophoresis in 12 % SDS-polyacrylamide gel, under reducing conditions, and transferred to a nitrocellulose membrane. After washing and blocking, the membranes were incubated overnight with anti-caspase-1 (1:5000; Cell Signaling; Danvers, USA) primary antibody. Afterwards, the membranes were exposed to the anti-rabbit (1:2000; Cell Signaling; Danvers, USA) secondary antibody. The immunocomplexes were visualized using the ECL chemiluminescence detection system (GE Healthcare, São Paulo, SP, Brazil). Membranes were stained with Pounceau in order to verify loading evenness.
Supernatants and cell lysates of astroglioma cell line and human primary astrocytes were collected after LPS and/or neopterin exposure. Cell culture supernatants were precipitated by the addition of an equal volume of methanol and 0.25 volumes of chloroform, followed by vortexing and centrifugation for 10 min at 20,000 × g. The upper phase was discarded and 500 mL methanol was added to the interphase. This mixture was centrifuged for 10 min at 20,000 × g and the protein pellet was dried up at 55°C, suspended in Laemmli buffer and boiled for Table 1 Primer used to assess expression of mouse inflammasome linked genes.
Genes
Forward Reverse 5 min at 99°C. Cell lysates were prepared in RIPA lysis buffer containing 50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 % Nonidet P-40 and 50 µL protease inhibitor cocktail (Roche, Mannheim, Germany). Thus, cell homogenates were centrifuged at 12,000 × g for 10 min at 4°C and the supernatant was collected. Cytosolic and nuclear fractions of C6 glioma cell line were obtained by centrifuging cell homogenate at 720 × g for 5 min at 4°C. The supernatant containing the cytoplasm, membranes and mitochondria were subsequently centrifuged at 10,000 × g for 10 min and at 100,000 × g for 1 h at 4°C to separate the cytosolic fraction. The pellet containing the nuclear fraction was washed and re-suspended in 0.1 % SDS. Protein content was quantified using the BCA Protein Assay kit (Thermo Scientific; Waltham, USA). Samples were diluted in 25 % Laemmni buffer (Bio-Rad; Hercules, USA) and 8 % β-mercaptoethanol. An aliquot of 15 µg of total protein was size-separated by electrophoresis in 4-15 % Mini-Protean® TGXTM gel (Bio-Rad; Hercules, USA) and transferred to a TransBlot® TurboTM Midi-size Nitrocellulose membrane (Bio-Rad; Hercules, USA). After washing and blocking, the membranes were incubated overnight with anti-ASC (1:500; Abcam; Cambridge, USA), anti-Caspase-1 (1:5000; Abcam; Cambridge, USA), anti-Nrf2 (1:250; Santa Cruz Biotechnology, Santa Cruz, CA, USA) and anti-hemeoxygenase-1 (HO-1) (1:500; Santa Cruz Biotechnology, Santa Cruz, CA, USA) primary antibodies. Afterwards, membranes were exposed to the anti-rabbit or anti-mouse secondary antibodies (1:10,000; Dako; Glostrup, Denmark). The immunocomplexes were detected using the Clarity™ Western ECL chemiluminescence detection system (Bio-Rad; Hercules, USA). Membranes were stripped and the content of GADPH (1:1000; Cell Signaling; Danvers, USA), anti-Tubulin (1:200; Sigma, Saint Louis, USA) or antiActin (1:1000; Sigma, Saint Louis, USA) were performed for verifying loading evenness.
Multiplexing cytokine analysis
Quantification of multiplexing cytokines were performed in astrocytes culture supernatant using 27-plex magnetic bead based immunoassay kits (Bio-Rad, CA, USA). The multiplex kit was used in order to measure human cytokines including IL-1β, IL-6, TNF-α, IL-10 and IL1ra in the samples (50 µL). The assay was performed in accordance with the manufacturer's instructions provided and it was carried out using the setup described by Khan [70] . All pipetting and mixing steps of the standards and samples (50 µL) with the assay reagents outlined in the manufacturer's protocol were performed with a programmed workflow using the robotic liquid handling workstation, epMotion 5075 (Eppendorf, Hamburg, Germany) in order to minimize pipetting errors. Subsequent washing and reading out was carried out with Bio-Plex Pro II wash station and Bio-Plex system 200, respectively (Bio-Rad, Hercules, USA). Final readout of the samples' concentration was calculated based on the standard curves integrated in the assay using the Bio-Plex Manager v5.0 8 % and expressed as percentage of controls.
Flow cytometry
C6 cells were exposed to 50 nM neopterin for 3 h. Afterwards, cells were suspended in 500 µL of PBS, containing 16 % formaldehyde for fixation for 10 min at 37°C. Then, cells were permeabilized in PBS containing 4 % saponin for 30 min, washed with PBS and incubated with anti-Nrf-2 primary antibody (1:1000; Cell Signaling; Danvers, USA) for 1 h. After removing the primary antibody with washing PBS, cells were incubated with anti-rabbit APC-conjugated secondary antibody (1:1000; Invitrogen; Carlsbad, USA) for 30 min at room temperature in the dark. Finally, cells were washed with PBS, suspended in 500 µL of PBS and transferred to specific flow cytometry tubes for fluorescence measurements. Samples were analyzed in a FACSCanto II flow cytometer (10,000 events / sample), using the program CellQuest 2.8 (BD Biosciences, San Jose, USA) (LAMEB, CCB, UFSC, Brazil). The results were analyzed using the ModFit 3 (Verity Software House) (BD Biosciences, San Jose, USA) program.
Mitochondrial respiratory chain activity
The hippocampi collected from neopterin-treated mice were used to measure the mitochondrial respiratory chain activity. NADH dehydrogenase activity, including complex I activity, was measured by the rate of NADH-dependent ferricyanide reduction at 420 nm (1 mM −1
. cm −1 ), as previously described [71] and the activity of the cytochrome c oxidase (complex IV) according to [72] . The methods described to measure these activities were slightly modified, as detailed in a previous report [73] . The activities of the respiratory chain complexes were calculated as nmol/min/mg protein.
Measurements of basal respiration
The basal respiration in C6 cells was measured under two different conditions. Initially, C6 rat astrocytes (500,000 cells/chamber) were added to each chamber, containing DMEM without FBS, in the highresolution oxygraph (Oxygraph-2 k Oroboros Instruments, Innsbruck, Austria) at 37°C. The oxygen consumption in basal conditions were recorded for 15 min. Then, crescent concentrations of neopterin (0.5-500 nM) or vehicle (DMSO 0.01 %) were added and the oxygen consumption until the last addition. The results were expressed as percentage of basal conditions. Then, C6 cells were seeded (1 × 10 4 cells/well) and, after reaching 80 % confluence, treated with neopterin 50 nM for 24 h. The medium was replaced by uncolor DMEM supplemented with 25 mM glucose, 1 mM pyruvate and 2 mM L-glutamine and the cells were incubated at 37°C in a CO 2 -free incubator for 1 h. The basal OCR was recorded for 18 min before adding the stressor mix (1 mg/mL oligomycin plus 1.2 mM FCCP) in a XF Seahorse Bioscience instrument (North Billerica, MA, USA), according to the protocol provided by the manufacturer. The average of the OCR values after the addition of the stressor mix was expressed as pmoles/ min.
Lactate release
Lactate levels in C6 cells supernatant was analyzed by a lactate analyzer (YSI 2700 STAT, Yellow Springs, Ohio, USA).
Superoxide anion production
C6 cells were pre-treated with neopterin (50 nM) for 24 h and then activated with LPS (5 μg/mL). After 24 h of LPS stimulation, the probe MitoSox™ (5 μM) was added and the cells kept for 10 min in the incubator. The cells were washed with PBS twice and the fluorescence was recorded using the microscope Olympus BX41 with integrated 3.3 megapixel camera Q-imaging in the Multiuser Laboratory for Biological Studies (LAMEB, CCB, UFSC, Brazil).
Hydrogen peroxide production
C6 cells were pre-treated with neopterin (50 nM) for 24 h and then activated with LPS (5 μg/mL). After 24 h of LPS stimulation, the probe Amplex® Red (Invitrogen, Carlsbad, USA) (50 μM) was added and the absorbance read for 30 min at excitation of 490 nm and emission of 585 nm using the Spectramax Paradigm Microplate Reader (Molecular Devices, Sunnyvale, USA).
Protein determination
Sample protein content was determined by Lowry's method using bovine serum albumin as the standard [69] .
Statistical analysis
Results are presented as mean ± SEM. Data was analyzed using oneway ANOVA followed by the post hoc of Dunnett or Tukey, when F was significant. Non-parametric data was analyzed using the Kruskal-Wallis test followed by Dunn's multiple comparisons test and Friedman's test followed by Wilcoxon Signed Ranks test for repeated measures. When comparing two independent or paired groups, Student t-test for independent or paired samples, respectively, was used. Only significant values are given in the text. Differences between the groups were rated significant at P < 0.05. Statistics were performed using SPSS (Statistical Package for the Social Sciences software; version 16.0 for Windows). All graphs were performed using GraphPad Prism 5®.
